CLOV Jan 2025 5.000 call
| Previous close | 0.0300 |
| Open | 0.0200 |
| Bid | 0.0200 |
| Ask | 0.0400 |
| Strike | 5.00 |
| Expiry date | 2025-01-17 |
| Day's range | 0.0200 - 0.0300 |
| Contract range | N/A |
| Volume | |
| Open interest | 2.76k |
Insider MonkeyClover Health Investments, Corp. (NASDAQ:CLOV) Q1 2024 Earnings Call Transcript
Clover Health Investments, Corp. (NASDAQ:CLOV) Q1 2024 Earnings Call Transcript May 7, 2024 Clover Health Investments, Corp. beats earnings expectations. Reported EPS is $-0.03941, expectations were $-0.07. Clover Health Investments, Corp. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies […]
GlobeNewswireClover Health Reports Strong First Quarter 2024 Financial Results; Improves Guidance to Target Full-Year 2024 Adjusted EBITDA Profitability
First Quarter 2024 Insurance Revenue growth of 8% year-over-year First Quarter 2024 GAAP Net Loss from Continuing Operations of $23.2 million versus First Quarter 2023 loss of $79.7 million First Quarter Adjusted EBITDA profitability of $6.8 million versus prior period loss of $37.5 million Improves 2024 guidance to Insurance Revenue of $1.30 billion - $1.35 billion and Adjusted EBITDA profitability of $10 million - $30 million Maintains strong liquidity position and view that Company has suffic
- GlobeNewswire
Clover Health to Participate at Bank of America 2024 Healthcare Conference and Present at 2024 Leerink Partners Healthcare Crossroads Conference
FRANKLIN, Tenn., May 01, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare, today announced its participation in the following investor conferences: CEO, Andrew Toy, and CFO, Peter Kuipers, will participate at the Bank of America 2024 Healthcare Conference on Wednesday, May 15, 2024.CEO, Andrew Toy, will present at
